Irritable
bowel syndrome is a gastrointestinal tract disorder characterized by
abdominal pain and altered bowel habits. It hampers the natural
movement of intestinal muscle linings to move food along the
digestive tract. Depending on the symptoms, the syndrome is
distinguished as mild and severe irritable bowel syndrome. These
symptoms include cramping, abdominal pain, bloating and gas, mucus in
the stool, constipation, and diarrhea. Exact cause of occurrence of
irritable bowel syndrome is unknown though, it is associated with
increased awareness of bodily functions, and abnormal
gastrointestinal tract movements. Diagnosis of irritable bowel
syndrome is done by tests such as blood tests, stool tests,
endoscopic procedures and external imaging procedures. Patients
suffering from irritable bowel syndrome may experience complications
namely, deep ulcerations, infections, and malnutrition and bowel
obstructions. Treatment of irritable bowel syndrome involves
relieving the patient from the symptoms and improving the quality of
life.
Ask
for Sample Copy of This Research @
https://www.coherentmarketinsights.com/insight/request-sample/506
Market
Dynamics
The
rise in number of gastrointestinal disorders are leading to
increasing prevalence of irritable bowel syndrome, for which various
companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs
conduct mass workshops for educating the people to incorporate
healthy food habits as a major precaution towards prevention of IBS.
Furthermore, major growth drivers for the irritable bowel syndrome
treatment market are expected launches of various pipeline drugs for
the treatment during the forecast period and increase in levels of
stress associated with changing lifestyle as people suffering from
IBS have a colon with sensitivity towards certain foods and stress.
According to a survey by Buscopan IBS Relief in 2016, stress was the
cause for seven out of ten patients suffering from gastrointestinal
pain. The large population of stress and anxiety disorder patients
are expected to fuel the growth of the global irritable bowel
syndrome treatment market.
The
global irritable bowel syndrome treatment market was valued at US$
726.1 million in 2016 and is expected to witness a robust CAGR of
12.9% over the forecast period (2017-2025).
Increase
in levels of stress and adoption of sedentary lifestyle is expected
to increase the prevalence of lifestyle disorders namely irritable
bowel syndrome
The
number of available irritable bowel syndrome drugs has increased over
the last few years and new drugs have been approved for the
treatment. North America accounts for the largest share in the global
irritable bowel syndrome treatment market, followed by Europe and
Asia-pacific, respectively. According to an article published in the
Brandon Gaille in 2017, on an average, junk food accounts for 28.8%
of the total caloric intake of an American. According to Centers for
Disease Control and Prevention (CDC) in 2015, it was estimated that
1.3% of U.S. adults i.e. 3 million were reported to being diagnosed
with IBD. Consumption of unhealthy food in large quantities raises
the bar of probability for IBS acting as a driving factor for the
global market growth.
Global
Key Players
Some
major players operating in the irritable bowel syndrome treatment
market are Abbott Laboratories, Synergy Pharmaceuticals, Inc.,
Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International,
Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG,
GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc.
Detailed
Segmentation:
Global
Irritable Bowel Syndrome Treatment Market, By Drug Type:
-
Lubiprostone
-
Linaclotide
-
Eluxadoline
-
Rifaximin
-
Ramosetron Hydrochloride
-
Others
Global
Irritable Bowel Syndrome Treatment Market, By Medical Condition:
-
IBS-Constipation
-
IBS-Diarrhea
Browse
In-Depth Analysis Research Report @
https://www.coherentmarketinsights.com/market-insight/irritable-bowel-syndrome-treatment-market-506
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
